Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-27 4:05 pm Purchase |
2024-11-25 | 13D | Citius Pharmaceuticals, Inc. CTXR |
Mazur Leonard L | 754,295 9.300% |
754,295 (New Position) |
Filing History |
| 2024-08-16 4:34 pm Purchase |
2024-08-12 | 13D | Citius Oncology, Inc. CTOR |
Citius Pharmaceuticals Inc. CTXR |
66,049,615 92.600% |
66,049,615 (New Position) |
Filing History |
| 2024-05-08 2:22 pm Purchase |
2024-04-30 | 13G | Citius Pharmaceuticals, Inc. CTXR |
BLACKROCK INC BLK |
345,034 4.800% |
6,721 (+1.99%) |
Filing History |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | Citius Pharmaceuticals, Inc. CTXR |
BLACKROCK INC BLK |
338,313 5.300% |
244,421 (+260.32%) |
Filing History |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Citius Pharmaceuticals, Inc. CTXR |
BLACKROCK INC BLK |
93,892 1.600% |
-231,239 (-71.12%) |
Filing History |
| 2022-02-18 4:31 pm Purchase |
2019-04-03 | 13D | Citius Pharmaceuticals, Inc. CTXR |
Mazur Leonard L | 723,685 11.760% |
280,719 (+63.37%) |
Filing History |
| 2022-02-18 4:30 pm Purchase |
2019-04-03 | 13D | Citius Pharmaceuticals, Inc. CTXR |
HOLUBIAK MYRON Z | 154,584 2.610% |
68,615 (+79.81%) |
Filing History |
| 2022-02-14 6:44 pm Sale |
2021-12-31 | 13G | Citius Pharmaceuticals, Inc. CTXR |
Armistice Capital, LLC | 97,000 1.600% |
-149,734 (-60.69%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Citius Pharmaceuticals, Inc. CTXR |
BLACKROCK INC BLK |
325,130 5.600% |
325,130 (New Position) |
Filing History |
| 2021-02-16 3:00 pm Purchase |
2020-12-31 | 13G | Citius Pharmaceuticals, Inc. CTXR |
Armistice Capital, LLC | 246,734 9.990% |
118,297 (+92.11%) |
Filing History |